Edition:
United States

Opexa Therapeutics Inc (OPXA.OQ)

OPXA.OQ on NASDAQ Stock Exchange Capital Market

1.08USD
2:16pm EDT
Change (% chg)

$0.00 (+0.47%)
Prev Close
$1.07
Open
$1.10
Day's High
$1.12
Day's Low
$1.07
Volume
30,317
Avg. Vol
64,618
52-wk High
$4.35
52-wk Low
$0.50

Chart for

About

Opexa Therapeutics, Inc. (Opexa) is a biopharmaceutical company. The Company is engaged in the development of a personalized immunotherapy with the potential to treat various illnesses, including multiple sclerosis (MS), as well as other autoimmune diseases, such as neuromyelitis optica (NMO). These therapies are based on its... (more)

Overall

Beta: 2.06
Market Cap(Mil.): $8.35
Shares Outstanding(Mil.): 7.66
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 80.15 16.18
EPS (TTM): -- -- --
ROI: -- 3.01 14.60
ROE: -- 4.76 13.87

BRIEF-Opexa Therapeutics reports qtrly loss per share $0.09

* Qtrly loss per share $0.09 Source text: [ID:http://bit.ly/2w2WrBD] Further company coverage:

Aug 14 2017

BRIEF-Opexa Therapeutics quarterly loss per share $0.12

* Opexa Therapeutics Inc - cash and cash equivalents were $2.8 million as of March 31, 2017, compared to $3.4 million as of December 31, 2016

May 12 2017

Competitors

Earnings vs. Estimates